CollPlant Appoints Bowman Bagley to Lead North American Commercial Operations

CollPlant Biotechnologies has appointed Bowman Bagley as Vice President, Commercial North America, a newly established role aimed at expanding the company’s commercial presence and operations in the region. Bagley will oversee sales, marketing, logistics, and strategic market development for CollPlant’s recombinant human collagen (rhCollagen)-based products and platforms.

“We are excited to welcome Bowman to the CollPlant leadership team as we scale our commercial operations and development programs," saidYehiel Tal, Chief Executive Officer of CollPlant. "His deep expertise in collagen-based biomaterials, 3D bioprinting, and tissue engineering aligns perfectly with our growth strategy. Bowman's proven track record in sales, product development, licensing, and operational execution will be instrumental as we grow our bioinks portfolio and expand rhCollagen sales to the research market as well as to strategic collaborators in the fields of regenerative and aesthetic medicine."

The appointment signals CollPlant’s intent to strengthen its footprint in North America as it advances its portfolio of regenerative and aesthetic medicine technologies. The company’s proprietary rhCollagen is derived from non-animal sources and is designed for use in a range of tissue repair and aesthetic applications.

Bagley brings a breadth of commercial and operational experience in the life sciences sector. He most recently served as Vice President and Fractional CxO at Wasatch Biolabs, a genomics research company, where he led revenue operations and growth strategy. Prior to that, he held executive roles at Advanced BioMatrix, a global provider of collagen and extracellular matrix products, culminating in his position as Chief Executive Officer. His tenure included leadership across product development, business development, and global sales.

In addition to his executive experience, Bagley has advised multiple life science startups on commercialization strategies and investment readiness. He is also an angel investor with NuFund Venture Group.

Bagley earned a bachelor’s degree in neuroscience from Brigham Young University and an MBA from the University of Utah.

CollPlant’s recruitment of a senior commercial executive aligns with its stated goals to advance the adoption of rhCollagen-based products and scale operations in key markets.